BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4286019)

  • 1. Plasma testosterone and urinary 17-ketosteroids in women with hirsutism and polycystic ovaries.
    Lloyd CW; Lobotsky J; Segre EJ; Kobayashi T; Taymor ML; Batt RE
    J Clin Endocrinol Metab; 1966 Mar; 26(3):314-24. PubMed ID: 4286019
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries.
    Bardin CW; Lipsett MB
    J Clin Invest; 1967 May; 46(5):891-902. PubMed ID: 6025489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hirsutism and hyperandrogenism.
    Givens JR
    Adv Intern Med; 1976; 21():221-47. PubMed ID: 130060
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease.
    Judd HL; Scully RE; Herbst AL; Yen SS; Ingersol FM; Kliman B
    Am J Obstet Gynecol; 1973 Dec; 117(7):976-82. PubMed ID: 4759835
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucocorticoid suppression of urinary testosterone excretion in patients with idiopathic hirsutism.
    Nichols T; Nugent CA; Tyler FH
    J Clin Endocrinol Metab; 1966 Jan; 26(1):79-86. PubMed ID: 4285285
    [No Abstract]   [Full Text] [Related]  

  • 6. Concentration of unconjugated adrenogenic hormones and their precursors in normal and polycystic ovaries.
    Györy G; Kiss C; Fehér T; Poteczin E
    Endokrinologie; 1975 Jan; 64(2):181-90. PubMed ID: 125194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TESTOSTERONE METABOLISM IN IDIOPATHIC HIRSUTISM.
    DELLER JJ; WEGIENKA LC; CONTE NF; ROSNER JM; FORSHAM PH
    Ann Intern Med; 1965 Sep; 63():369-76. PubMed ID: 14327503
    [No Abstract]   [Full Text] [Related]  

  • 8. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency.
    Pang SY; Softness B; Sweeney WJ; New MI
    N Engl J Med; 1987 May; 316(21):1295-301. PubMed ID: 3472077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of a gas chromatographic method for the combined determination of testosterone and epitestosterone glucuronide in urine.
    Futterweit W; Freeman R; Siegel GL; Griboff SI; Dorfman RI; Soffer LJ
    J Clin Endocrinol Metab; 1965 Nov; 25(11):1451-6. PubMed ID: 4284769
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined dexamethasone and human chorionic gonadotropin in diagnosis of polycystic ovarian disease.
    Beck WW; McEvoy D; Wallach EE
    Obstet Gynecol; 1971 Feb; 37(2):211-7. PubMed ID: 5539356
    [No Abstract]   [Full Text] [Related]  

  • 11. URINARY STEROID EXCRETION PATTERNS IN HIRSUTISM. II. EFFECT OF OVARIAN STIMULATION WITH HUMAN PITUITARY FSH ON URINARY 17-KETOSTEROIDS.
    MAHESH VB; GREENBLATT RB
    J Clin Endocrinol Metab; 1964 Dec; 24():1293-302. PubMed ID: 14243173
    [No Abstract]   [Full Text] [Related]  

  • 12. Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma.
    Givens JR; Kerber IJ; Wiser WL; Andersen RN; Coleman SA; Fish SA
    J Clin Endocrinol Metab; 1974 Mar; 38(3):347-55. PubMed ID: 4360917
    [No Abstract]   [Full Text] [Related]  

  • 13. PLASMA ANDROGENS IN WOMEN. II. PATIENTS WITH POLYCYSTIC OVARIES AND HIRSUTISM.
    DIGNAM WJ; PION RJ; LAMB EJ; SIMMER HH
    Acta Endocrinol (Copenh); 1964 Feb; 45():254-71. PubMed ID: 14123324
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian hyperthecosis in the adolescent patient.
    Wentz AC; Gutai JP; Jones GS; Migeon CJ
    J Pediatr; 1976 Mar; 88(3):488-93. PubMed ID: 1107505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The urinary elimination of 17-hydroxycorticosteroids and 17-ketosteroids in some dynamico-idiopathic functional tests in simple obesity, hirsutism and ovarian polycystic disease].
    Lodeserto A; Reschini E; Giustina G
    Arch Maragliano Patol Clin; 1968; 24(4):443-55. PubMed ID: 4303680
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adrenal cortex and ovarian intervention in the pathogenesis of minor hyperandrogenism. I. Study of fractionated urinary 17-ketosteroids in basal and dynamic conditions in 30 women with hirsutism].
    Minozzi M; Faggiano M; Salerno M; Orio F; Lombardi G; Jori JP
    Folia Endocrinol; 1967 Dec; 20(6):736-64. PubMed ID: 4303786
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination of ACTH dexamethazone and HCG in the differential diagnosis of hirsutism and polycystic ovaries (author's transl)].
    Divila F; Presl J; Stroufová A; Kozlová J; Horský J
    Cesk Gynekol; 1973 Sep; 38(8):627-9. PubMed ID: 4358102
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of estrogen administration on androgen production and plasma luteinizing hormone in hirsute women.
    Kirschner MA; Bardin CW; Hembree WC; Ross GT
    J Clin Endocrinol Metab; 1970 Jun; 30(6):727-32. PubMed ID: 5444560
    [No Abstract]   [Full Text] [Related]  

  • 19. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency.
    Pittaway DE
    N Engl J Med; 1988 Jan; 318(3):190-1. PubMed ID: 3422107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.